Remember when Tylenol was linked to autism, crashing the stock price of its maker just long enough for that business to be acquired at a steep discount by its new owner? And how we never heard about a link between Tylenol and autism again?
I wonder which vaccine maker is about to get a hostile takeover?
In November 2025, Kimberly-Clark announced it would buy Tylenol producer Kenvue for $48.7 billion. The deal would add the Aveeno, Band-Aid, Benadryl, Benylin, Calpol, Carefree, Clean & Clear, Combantrin, Imodium, Listerine, Motrin, Mylanta, Neutrogena, Nicorette, Johnson’s Baby, Sudafed, Visine, and Zyrtec brands to the company’s portfolio.
But also…
Kimberly-Clark shares are mainly held by institutional investors (The Vanguard Group, BlackRock, State Street Corporation, and others).
Remember when Tylenol was linked to autism, crashing the stock price of its maker just long enough for that business to be acquired at a steep discount by its new owner? And how we never heard about a link between Tylenol and autism again?
I wonder which vaccine maker is about to get a hostile takeover?
I don’t who is the new owner? Bayer? ‘Cause that’d fit.
Kimberly-Clark apparently.
But also…
So make of that what you will.
I REMEMBER